Why Merck's Provata acquisition could portend more health care M & A
Look for increased deal activity as investors hunt for promising health IT startups and drugmakers look for ways to reduce overall health care costs as public scrutiny intensifies.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Elizabeth Hayes Source Type: news
More News: Biotechnology | Health Management | Information Technology | Merck | Mergers and Aquisitions